Loading clinical trials...

Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients | Clinical Trials | Clareo Health

TERMINATED

Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients

AN OPEN LABEL, NON-INTERVENTIONAL STUDY OF THE SAFETY, TOLERABILITY, AND EFFICACY OF AMLODIPINE AND OLMESARTAN MEDOXOMIL (NORMETECTM) IN FILIPINO PATIENTS WITH HYPERTENSION: A POST MARKETING SURVEILLANCE STUDY

NCT01200407•Pfizer

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine the safety, tolerability and efficacy of Amlodipine and Olmesartan medoxomil among Hypertensive Filipino patients.

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Filipino hypertensive subjects ages 18-65 years old whether naive or currently taking any other anti-hypertensive or those on monotherapy using CCBs or ARBs whom they want to shift on a fixed dose combination drug

Exclusion Criteria

•Patients with contraindications to any of the component of the fixed drug (amlodipine or olmesartan medoxomil) or with malignant or secondary hypertension

Locations (52)

Lorma Medical Center

San Fernando City, LA Union, Philippines

Holy Child Hospital

Taclobo, Dumaguete City, Negros Oriental, Philippines

Private Clinic

Albay, Philippines

Private Clinic

Angono, Philippines

Pines City Doctors Hospital

Baguio City, Philippines

Private Clinic

Baguio City, Philippines

Private Clinic

Bulacan, Philippines

Private Clinic

Calamba, Philippines

Private Clinic

Cavite, Philippines

Private Clinic

Cebu, Philippines

Key Dates

Start Date

June 9, 2010

Primary Completion Date

January 4, 2014

Completion Date

January 4, 2014

Last Updated

August 17, 2021

Enrollment

615

ACTUAL participants

Conditions

Hypertension

Interventions

Amlodipine + Olmesartan medoxomil

DRUG

Natural History of Noncirrhotic Portal Hypertension

NCT02417740

Cystic FibrosisImmunologic Deficiency Syndrome+3 more

View study

RECRUITING

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

NCT07480265

Hypertension (HTN)Hyperhomocysteinemia+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 17, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients

Inclusion Criteria

Exclusion Criteria

Natural History of Noncirrhotic Portal Hypertension

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication

Penn Medicine Healthy Heart

Preliminary Human Trials of F230 Tablets